EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
Ann Rheum Dis. 2026 Mar 12:S0003-4967(26)00075-0. doi: 10.1016/j.ard.2026.01.023. Online ahead of print.ABSTRACTOBJECTIVES: This study aims to provide an update of the European Alliance of Associations for Rheumatology (EULAR) rheumatoid arthritis (RA) management recommendations addressing the most

